Difficulty in evaluating the stability of multi-particulate capsules.
In the pharmaceutical industry, ensuring the stability of drug products is crucial for maintaining their efficacy, safety, and quality over their shelf life. Multi-particulate capsules, which contain numerous small, discrete particles within a single dosage form, offer several advantages such as flexible dosing and improved bioavailability. However, evaluating the stability of these complex formulations poses unique challenges that must be addressed to ensure compliance with regulatory standards and to guarantee therapeutic efficacy.
Click to read the full article.